Back
Verve Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
VERV
Verve Therapeutics
Last Price:
4.85
Seasonality Move:
-11.16%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
Verve Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.91 | Sell |
| 20-day SMA: | 5.65 | Sell |
| 50-day SMA: | 5.36 | Sell |
| 200-day SMA: | 7.32 | Sell |
| 8-day EMA: | 4.99 | Sell |
| 20-day EMA: | 5.35 | Sell |
| 50-day EMA: | 5.47 | Sell |
| 200-day EMA: | 7.4 | Sell |
Verve Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 40.26 | Sell |
| Chaikin Money Flow: | 1039980 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.04 - 6.28) | Sell |
| Bollinger Bands (100): | (4.83 - 6.53) | Sell |
Verve Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Verve Therapeutics Stock
Is Verve Therapeutics Stock a Buy?
- Verve Therapeutics share price is 4.85 while VERV 8-day simple moving average is 4.91, which is a Sell signal.
- The stock price of VERV is 4.85 while Verve Therapeutics 20-day SMA is 5.65, which makes it a Sell.
- Verve Therapeutics 50-day simple moving average is 5.36 while VERV share price is 4.85, making it a Sell technically.
- VERV stock price is 4.85 and Verve Therapeutics 200-day simple moving average is 7.32, creating a Sell signal.
VERV Technical Analysis vs Fundamental Analysis
Sell
25
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy or a Sell?
-
Verve Therapeutics stock is rated a Sell
The current Verve Therapeutics [VERV] share price is $4.85. The Score for VERV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Verve Therapeutics Stock Info
Market Cap:
410.62M
Price in USD:
4.85
Share Volume:
1.13M
Verve Therapeutics 52-Week Range
52-Week High:
19.34
52-Week Low:
4.31
Sell
25
Verve Therapeutics (VERV)
is a Sell
Verve Therapeutics Share Price Forecast
-
What is the Verve Therapeutics stock price today?
The Verve Therapeutics stock price is 4.85 USD today. -
Will VERV stock go up or go down?
Verve Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Verve Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verve Therapeutics is overvalued.
Is Verve Therapeutics Stock a Buy?
- Verve Therapeutics share price is 4.85 while VERV 8-day exponential moving average is 4.99, which is a Sell signal.
- The stock price of VERV is 4.85 while Verve Therapeutics 20-day EMA is 5.35, which makes it a Sell.
- Verve Therapeutics 50-day exponential moving average is 5.47 while VERV share price is 4.85, making it a Sell technically.
- VERV stock price is 4.85 and Verve Therapeutics 200-day simple moving average is 7.40, creating a Sell signal.
Fundamental Analysis of Verve Therapeutics
Is Verve Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Verve Therapeutics
Should I short Verve Therapeutics stock?
- VERV Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Verve Therapeutics is a Sell
- Verve Therapeutics Relative Strength Index (RSI) is 40.26, which suggest Verve Therapeutics is oversold
- The Bollinger Bands (25) for Verve Therapeutics is (5.04 - 6.28), which suggest Verve Therapeutics is a Sell
- The Bollinger Bands (100) for Verve Therapeutics is (4.83 - 6.53), which suggest Verve Therapeutics is a Sell
* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.